Elevation of serum KL-6 levels during treatment with tumor necrosis factor-α inhibitor in patients with psoriasis

被引：9
|
作者：
Mabuchi, Tomotaka [1 ]
Yamaoka, Hanako [1 ]
Kawai, Mayu [1 ]
Ota, Tami [1 ]
Ozawa, Akira [1 ]
机构：
[1] Tokai Univ, Dept Dermatol, Sch Med, Isehara, Kanagawa 2591193, Japan
来源：
JOURNAL OF DERMATOLOGY | 2014年 / 41卷 / 12期
关键词：
AD HOC COMMITTEE; RHEUMATOID-ARTHRITIS; BIOLOGICAL DMARDS; JAPAN COLLEGE; SAFETY;
D O I：
10.1111/1346-8138.12681
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：1136 / 1137
页数：2
相关论文
共 50 条
  • [31] Tumour necrosis factor- inhibitor use in patients with psoriasis with organ transplantation
    Mansouri, B.
    Patel, M.
    Menter, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) : 481 - 483
  • [32] Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
    S Endo
    Y Yamada
    K Inada
    S Sato
    Critical Care, 4 (Suppl 1):
  • [33] Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple Sclerosis
    Mansouri, Bobbak
    Horner, Mary E.
    Menter, Alan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 876 - 878
  • [34] Tumor necrosis factor-α (TNFα) inhibitor-induced psoriasis in juvenile idiopathic arthritis (JIA) patients
    Groth, Daniel
    Lapidus, Sivia
    Nativ, Simona
    Perez, Maria
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 74 - 75
  • [35] Serum KL-6 levels in pediatric patients: Reference values for children and levels in pneumonia, asthma, and measles patients
    Imai, T
    Takase, M
    Takeda, S
    Kougo, T
    PEDIATRIC PULMONOLOGY, 2002, 33 (02) : 135 - 141
  • [36] Serum leptin levels and their relationship to tumor necrosis factor-α and interleukin-6 in neonatal sepsis
    Koç, E
    Üstündag, G
    Aliefendioglu, D
    Ergenekon, E
    Bideci, A
    Atalay, Y
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (09): : 1283 - 1287
  • [37] Serum KL-6 Levels in Lung Cancer Patients With or Without Interstitial Lung Disease
    Miyazaki, Kunihiko
    Kurishima, Koichi
    Kagohashi, Katsunori
    Kawaguchi, Mio
    Ishikawa, Hiroichi
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2010, 24 (05) : 295 - 299
  • [38] The clinical significance of serum KL-6 levels in patients with type C liver diseases
    Moriyama, M
    Matsumura, H
    Mikuni, M
    Arkawa, Y
    Ohshiro, S
    Aoki, H
    Yamagami, H
    Kaneko, M
    Shioda, A
    Saito, H
    Tanaka, N
    Arakawa, Y
    HEPATOLOGY RESEARCH, 2003, 25 (04) : 385 - 395
  • [39] Serum Plasminogen Activator Inhibitor-1 and Tumor Necrosis Factor-α Levels in Obesity and Periodontal Disease
    Akman, Pelin Tasdelen
    Fentoglu, Ozlem
    Yilmaz, Gulin
    Arpak, Nejat
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (08) : 1057 - 1062
  • [40] Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
    Oh, Gyu Man
    Moon, Won
    INTESTINAL RESEARCH, 2020, 18 (03) : 245 - 246
12345